Amgen's fast-growing cancer immunotherapy Imdelltra could move into the first-line setting in small cell lung cancer (SCLC), ...

The pivotal QUINTESSENTIAL trial of the potentially first-in-class CAR-T showed a "statistically significant and clinically ...

The FDA has started a priority review of AstraZeneca's IL-33-targeting antibody tozorakimab for chronic obstructive pulmonary ...

An AI-powered imaging tool developed by Brainomix has been used to enrich data from a phase 2a trial of Endeavor BioMedicines ...

Registration and the full programme are available on the DIA-MHRA Global Summit page. Follow the conversation at ...

Every few years, drug development goes through a moment where a new technology promises to change everything. Artificial ...

Different regions have distinct healthcare systems, varying access levels, reimbursement models, and treatment realities — ...

Hydroxychloroquine, the anti-malaria drug controversially used to fight COVID-19, was trending again after a string of retweets from president Donald Trump in favour of the medicine. Trump has ...

Understanding the needs and behaviour of healthcare professionals is the number one priority for pharma as it interacts with the medical profession in 2024, marking a gradual shift away from a focus ...

Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...

Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the US, shrugging off the weakness in stock markets caused by President Trump's ...

Hippocratic AI has expanded its focus with the acquisition of Grove AI, a specialist in AI used in pharma R&D, to complement its current activities in patient-facing, generative AI (GenAI) agents.